{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:46Z","timestamp":1793459686627,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01622-5","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T03:23:09Z","timestamp":1732764189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort"],"prefix":"10.1186","volume":"16","author":[{"given":"Matteo","family":"Tonietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Sotolongo-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Ro\u00e9-Vellv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Bullich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Tartari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilio","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Castell-Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"T\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the FACEHBI study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Alarc\u00f3n-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Alegret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Alllu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Appiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DM","family":"Ariton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Bojaryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Buendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ca\u00f1abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ca\u00f1ada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"de Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gailhajenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"G\u00f3mez-Chiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ibarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Lleonart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Lome\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Morera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Montrreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ni\u00f1erola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AB","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pelej\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"P\u00e9rez-Cordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"P\u00e9rez-Grijalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pascual-Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Perissinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Preckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Pytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI","family":"Ramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rosende-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sarasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Seguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Tejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Terencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the AMYPAD consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"1622_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359 Springer-Verlag.","journal-title":"Acta Neuropathol"},{"key":"1622_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2012;8:1\u201313.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1622_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/alz.12618","volume":"18","author":"H Zetterberg","year":"2022","unstructured":"Zetterberg H. Biofluid-based biomarkers for Alzheimer\u2019s disease\u2013related pathologies: An update and synthesis of the literature. Alzheimer\u2019s Dement. 2022;18:1687.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1622_CR4","first-page":"CD009628","volume":"3","author":"G Lombardi","year":"2020","unstructured":"Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, et al. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment. Cochrane database Syst Rev. 2020;3:CD009628.","journal-title":"Cochrane database Syst Rev"},{"key":"1622_CR5","doi-asserted-by":"publisher","first-page":"624330","DOI":"10.3389\/fnagi.2021.624330","volume":"13","author":"W Bao","year":"2021","unstructured":"Bao W, Xie F, Zuo C, Guan Y, Huang YH. PET neuroimaging of Alzheimer\u2019s disease: radiotracers and their utility in clinical research. Front Aging Neurosci. 2021;13:624330.","journal-title":"Front Aging Neurosci"},{"key":"1622_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","volume":"35","author":"G Cassinelli Petersen","year":"2022","unstructured":"Cassinelli Petersen G, Roytman M, Chiang GC, Li Y, Gordon ML, Franceschi AM. Overview of tau PET molecular imaging. Curr Opin Neurol. 2022;35:230\u20139.","journal-title":"Curr Opin Neurol"},{"key":"1622_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","volume":"14","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. Lancet Neurol. 2015;14:114\u201324.","journal-title":"Lancet Neurol"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1053\/j.semnuclmed.2017.06.003","volume":"47","author":"CA Mathis","year":"2017","unstructured":"Mathis CA, Lopresti BJ, Ikonomovic MD, Klunk WE. Small-molecule PET Tracers for Imaging Proteinopathies. Semin Nucl Med. 2017;47:553\u201375.","journal-title":"Semin Nucl Med"},{"key":"1622_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, et al. PET imaging of Tau deposition in the aging human brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"1622_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack","year":"2018","unstructured":"Jack CR, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain. 2018;141:1517\u201328.","journal-title":"Brain"},{"key":"1622_CR11","doi-asserted-by":"crossref","unstructured":"Leuzy A, Smith R, Cullen NC, Strandberg O, Vogel JW, Binette AP, et al. Biomarker-based prediction of longitudinal tau positron emission tomography in Alzheimer disease. JAMA Neurol. 2021. Available from: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2787209.","DOI":"10.1001\/jamaneurol.2021.4654"},{"key":"1622_CR12","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28:2381\u20137.","journal-title":"Nat Med"},{"key":"1622_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.15252\/emmm.201707809","volume":"9","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Sch\u00f6ll M, Strandberg O, Smith R, Palmqvist S, Insel PS, et al. 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer\u2019s disease. EMBO Mol Med. 2017;9:1212\u201323.","journal-title":"EMBO Mol Med"},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1038\/s41380-021-01263-2","volume":"26","author":"M Bucci","year":"2021","unstructured":"Bucci M, Chiotis K, Nordberg A. Alzheimer\u2019s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021;26:5888\u201398.","journal-title":"Mol Psychiatry"},{"key":"1622_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamaneurol.2019.4749","volume":"77","author":"PF Meyer","year":"2020","unstructured":"Meyer PF, Pichet Binette A, Gonneaud J, Breitner JCS, Villeneuve S. Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated Tau and AV1451 positron emission tomography. JAMA Neurol. 2020;77:508\u201316.","journal-title":"JAMA Neurol"},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14020110","volume":"14","author":"CVML Jie","year":"2021","unstructured":"Jie CVML, Treyer V, Schibli R, Mu L. Tauvid\u2122: The first FDA-approved PET tracer for imaging Tau pathology in Alzheimer\u2019s disease. Pharmaceuticals (Basel). 2021;14:1\u201312.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1622_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00259-021-05673-w","volume":"49","author":"M Tian","year":"2022","unstructured":"Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, et al. International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2022;49:895\u2013904.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1622_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marqui\u00e9","year":"2015","unstructured":"Marqui\u00e9 M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015;78:787.","journal-title":"Ann Neurol"},{"key":"1622_CR19","first-page":"232","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimer\u2019s Dement (Amsterdam, Netherlands). 2018;10:232\u20136.","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"key":"1622_CR20","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1021\/acschemneuro.9b00326","volume":"10","author":"LR Drake","year":"2019","unstructured":"Drake LR, Pham JM, Desmond TJ, Mossine AV, Lee SJ, Kilbourn MR, et al. Identification of AV-1451 as a weak, nonselective inhibitor of monoamine oxidase. ACS Chem Neurosci. 2019;10:3839\u201346 Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acschemneuro.9b00326.","journal-title":"ACS Chem Neurosci"},{"key":"1622_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","volume":"77","author":"A Leuzy","year":"2020","unstructured":"Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, et al. Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of alzheimer disease from other neurodegenerative disorders. JAMA Neurol. 2020;77:955\u201365.","journal-title":"JAMA Neurol"},{"key":"1622_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.119.236224","volume":"61","author":"A Mueller","year":"2020","unstructured":"Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, et al. Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. J Nucl Med. 2020;61:911\u20139.","journal-title":"J Nucl Med"},{"key":"1622_CR23","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","volume":"46","author":"H Kroth","year":"2019","unstructured":"Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, et al. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies. Eur J Nucl Med Mol Imaging. 2019;46:2178\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1622_CR24","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.1021\/acs.jmedchem.1c00861","volume":"64","author":"H Kroth","year":"2021","unstructured":"Kroth H, Oden F, Molette J, Schieferstein H, Gabellieri E, Mueller A, et al. PI-2620 lead optimization highlights the importance of off-target assays to develop a PET tracer for the detection of pathological aggregated Tau in Alzheimer\u2019s disease and other tauopathies. J Med Chem. 2021;64:12808\u201330.","journal-title":"J Med Chem"},{"key":"1622_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2967\/jnumed.117.196741","volume":"59","author":"M Honer","year":"2018","unstructured":"Honer M, Gobbi L, Knust H, Kuwabara H, Muri D, Koerner M, et al. Preclinical evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as novel PET radiotracers for imaging Tau aggregates in Alzheimer disease. J Nucl Med. 2018;59:675\u201381.","journal-title":"J Nucl Med"},{"key":"1622_CR26","doi-asserted-by":"publisher","first-page":"105226","DOI":"10.1016\/j.parkreldis.2022.11.018","volume":"106","author":"K Oliveira Hauer","year":"2023","unstructured":"Oliveira Hauer K, Pawlik D, Leuzy A, Janelidze S, Hall S, Hansson O, et al. Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy. Park Relat Disord. 2023;106:105226. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.11.018.","journal-title":"Park Relat Disord"},{"key":"1622_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, et al. The Centiloid project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s Dement. 2015;11:1\u201315.e4.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1622_CR28","unstructured":"Leuzy A, Raket LL, Villemagne VL, Klein G, Tonietto M, Olafson E, et al. Harmonizing tau positron emission tomography in Alzheimer\u2019s disease: the CenTauR scale and the joint propagation model. Alzheimers Dement. 2024. Available from:\u00a0https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.13908."},{"key":"1622_CR29","first-page":"100","volume":"4","author":"O Rodriguez-Gomez","year":"2017","unstructured":"Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, et al. FACEHBI: a prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols. J Prev Alzheimer\u2019s Dis. 2017;4:100\u20138.","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"1622_CR30","doi-asserted-by":"publisher","first-page":"17721","DOI":"10.1038\/s41598-020-74704-7","volume":"10","author":"A P\u00e9rez-Cord\u00f3n","year":"2020","unstructured":"P\u00e9rez-Cord\u00f3n A, Mont\u00e9-Rubio G, Sanabria A, Rodriguez-Gomez O, Valero S, Abdelnour C, et al. Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort. Sci Rep. 2020;10:17721.","journal-title":"Sci Rep"},{"key":"1622_CR31","doi-asserted-by":"publisher","first-page":"5232184","DOI":"10.1155\/2020\/5232184","volume":"2020","author":"N Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz N, Gom\u00e0-I-Freixanet M, Valero S, Rodr\u00edguez-G\u00f3mez O, Sanabria A, P\u00e9rez-Cord\u00f3n A, et al. Personality factors and subjective cognitive decline: the FACEHBI cohort. Behav Neurol. 2020;2020:5232184.","journal-title":"Behav Neurol"},{"key":"1622_CR32","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/s41598-018-21644-y","volume":"8","author":"A Sanabria","year":"2018","unstructured":"Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Mont\u00e9-Rubio G, et al. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep. 2018;8:3828.","journal-title":"Sci Rep"},{"key":"1622_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0329-8","volume":"10","author":"I De Rojas","year":"2018","unstructured":"De Rojas I, Romero J, Rodr\u00edguez-Gomez O, Pesini P, Sanabria A, P\u00e9rez-Cordon A, et al. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundaci\u00f3 ACE Healthy Brain Initiative (FACEHBI) 11 medical and health sciences 1109 neurosciences. Alzheimer\u2019s Res Ther. 2018;10:1.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1622_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jalz.2017.10.005","volume":"14","author":"S Moreno-Grau","year":"2018","unstructured":"Moreno-Grau S, Rodr\u00edguez-G\u00f3mez O, Sanabria \u00c1, P\u00e9rez-Cord\u00f3n A, S\u00e1nchez-Ruiz D, Abdelnour C, et al. Exploring APOE genotype effects on Alzheimer\u2019s disease risk and amyloid \u03b2 burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. Alzheimer\u2019s Dement. 2018;14:634\u201343.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1622_CR35","doi-asserted-by":"publisher","first-page":"1076177","DOI":"10.3389\/fnins.2023.1076177","volume":"17","author":"M Marqui\u00e9","year":"2023","unstructured":"Marqui\u00e9 M, Garc\u00eda-S\u00e1nchez A, Alarc\u00f3n-Mart\u00edn E, Mart\u00ednez J, Castilla-Mart\u00ed M, Castilla-Mart\u00ed L, et al. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer\u2019s disease in individuals with mild cognitive impairment: the NORFACE cohort. Front Neurosci. 2023;17:1076177.","journal-title":"Front Neurosci"},{"key":"1622_CR36","doi-asserted-by":"publisher","first-page":"e76436","DOI":"10.1371\/journal.pone.0076436","volume":"8","author":"M Alegret","year":"2013","unstructured":"Alegret M, Espinosa A, Valero S, Vinyes-Junqu\u00e9 G, Ruiz A, Hern\u00e1ndez I, et al. Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old. PLoS ONE. 2013;8:e76436.","journal-title":"PLoS ONE"},{"key":"1622_CR37","doi-asserted-by":"publisher","first-page":"e76436","DOI":"10.1371\/journal.pone.0076436","volume":"8","author":"M Alegret","year":"2013","unstructured":"Alegret M, Espinosa A, Valero S, Vinyes-Junqu\u00e9 G, Ruiz A, Hern\u00e1ndez I, et al. Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish individual adults older than 44 years old. PLoS One. 2013;8:e76436.","journal-title":"PLoS One"},{"key":"1622_CR38","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dor\u00e9 V, Jones G, Baxendale D, Mulligan RS, Bullich S, et al. 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids. Eur J Nucl Med Mol Imaging. 2017;44:2053\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1622_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00807-6","volume":"13","author":"S Bullich","year":"2021","unstructured":"Bullich S, Ro\u00e9-Vellv\u00e9 N, Marqui\u00e9 M, Landau SM, Barthel H, Villemagne VL, et al. Early detection of amyloid load using 18F-florbetaben PET. Alzheimers Res Ther. 2021;13:1.","journal-title":"Alzheimers Res Ther"},{"key":"1622_CR40","doi-asserted-by":"publisher","first-page":"117012","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M. FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. Neuroimage. 2020;219:117012. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117012.","journal-title":"Neuroimage"},{"key":"1622_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80:247\u201358.","journal-title":"Ann Neurol"},{"key":"1622_CR42","doi-asserted-by":"publisher","first-page":"103368","DOI":"10.1016\/j.nicl.2023.103368","volume":"38","author":"A Yazdan-Panah","year":"2023","unstructured":"Yazdan-Panah A, Schmidt-Mengin M, Ricigliano VAG, Soulier T, Stankoff B, Colliot O. Automatic segmentation of the choroid plexuses: method and validation in controls and patients with multiple sclerosis. NeuroImage Clin. 2023;38:103368.","journal-title":"NeuroImage Clin"},{"key":"1622_CR43","first-page":"253","volume":"50","author":"M Brudfors","year":"2020","unstructured":"Brudfors M, Balbastre Y, Flandin G, Nachev P, Ashburner J. Flexible bayesian modelling for nonlinear image registration. MICCAI-2020. 2020;50:253\u201363.","journal-title":"MICCAI-2020"},{"key":"1622_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroimage.2006.05.056","volume":"33","author":"J Diedrichsen","year":"2006","unstructured":"Diedrichsen J. A spatially unbiased atlas template of the human cerebellum. Neuroimage. 2006;33:127\u201338.","journal-title":"Neuroimage"},{"key":"1622_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hbm.1058","volume":"15","author":"TE Nichols","year":"2001","unstructured":"Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging experiments: a primer with examples. Hum Brain Mapp. 2001;15:1\u201325 Available from: http:\/\/www3.interscience.wiley.com\/cgi-bin\/abstract\/86010644\/.","journal-title":"Hum Brain Mapp"},{"key":"1622_CR46","doi-asserted-by":"publisher","first-page":"102708","DOI":"10.1016\/j.nicl.2021.102708","volume":"31","author":"R Smith","year":"2021","unstructured":"Smith R, Strandberg O, Leuzy A, Betthauser TJ, Johnson SC, Pereira JB, et al. Sex differences in off-target binding using tau positron emission tomography. NeuroImage Clin. 2021;31:102708. https:\/\/doi.org\/10.1016\/j.nicl.2021.102708.","journal-title":"NeuroImage Clin"},{"key":"1622_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2967\/jnumed.122.263948","volume":"64","author":"S Flores","year":"2023","unstructured":"Flores S, Chen CD, Su Y, Dincer A, Keefe SJ, McKay NS, et al. Investigating Tau and amyloid tracer skull binding in studies of Alzheimer disease. J Nucl Med. 2023;64:287\u201393.","journal-title":"J Nucl Med"},{"key":"1622_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","volume":"5","author":"M Marqui\u00e9","year":"2017","unstructured":"Marqui\u00e9 M, Verwer EE, Meltzer AC, Kim SJW, Ag\u00fcero C, Gonzalez J, et al. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case. Acta Neuropathol Commun. 2017;5:75.","journal-title":"Acta Neuropathol Commun"},{"key":"1622_CR49","doi-asserted-by":"publisher","first-page":"117193","DOI":"10.1016\/j.neuroimage.2020.117193","volume":"221","author":"D Pawlik","year":"2020","unstructured":"Pawlik D, Leuzy A, Strandberg O, Smith R. Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET. Neuroimage. 2020;221:117193. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117193.","journal-title":"Neuroimage"},{"key":"1622_CR50","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaneurol.2023.1067","volume":"80","author":"A Leuzy","year":"2023","unstructured":"Leuzy A, Binette AP, Vogel JW, Klein G, Borroni E, Tonietto M, et al. Comparison of group-level and individualized brain regions for measuring change in longitudinal Tau positron emission tomography in Alzheimer disease. JAMA Neurol. 2023;80:614 Available from: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2804754.","journal-title":"JAMA Neurol"},{"key":"1622_CR51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00259-019-04496-0","volume":"47","author":"R Smith","year":"2020","unstructured":"Smith R, Sch\u00f6ll M, Leuzy A, J\u00f6gi J, Ohlsson T, Strandberg O, et al. Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948. Eur J Nucl Med Mol Imaging. 2020;47:342\u201354 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31612245.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1622_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2967\/jnumed.120.254961","volume":"63","author":"A Gogola","year":"2022","unstructured":"Gogola A, Minhas DS, Villemagne VL, Cohen AD, Mountz JM, Pascoal TA, et al. Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects. J Nucl Med. 2022;63:108\u201316 Available from: http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.254961.","journal-title":"J Nucl Med"},{"key":"1622_CR53","doi-asserted-by":"crossref","unstructured":"Young P, Thomas WP, Axelsson J, Himmelmann J, Dominguez PA, Ohlsson T, et al. Impact of reduced injected dose on the quantification of [ 18 F]RO948 and [ 18 F]Flortaucipir PET for in vivo tau pathology. Alzheimer\u2019s Dement. 2021;17. Available from:\u00a0https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.055951.","DOI":"10.1002\/alz.055951"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01622-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:19:08Z","timestamp":1732781948000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01622-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01622-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The TAU-PET FACEHBI protocol received the approval from the Spanish Drug Agency (AEMPS for its initials in Spanish) and was registered as phase II clinical trial (CT) (EudraCT: 2021-000473-83, approval date December 15<sup>th<\/sup> 2021) and by the Ethics Committee of Hospital Universitari de Bellvitge in Hospitalet de Llobregat, Spain. The FACEHBI-2 protocol (which includes study v5) was approved by the Ethics Committee of Hospital Cl\u00ednic i Provincial in Barcelona, Spain. Informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai and Servier. She received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche and Servier. She reports grants\/research funding from Abbvie, Araclon, Biogen Research Limited, Bioiberica, Grifols, Lilly, S.A, Merck Sharp & Dohme, Kyowa Hakko Kirin, Laboratorios Servier, Nutricia SRL, Oryzon Genomics, Piramal Imaging Limited, Roche Pharma SA, and Schwabe Farma Iberica SLU, all outside the submitted work. She has not received personal compensations from these organizations. AR is member of scientific advisory board of Landsteiner Genmed and Grifols SA. AR has stocks of Landsteiner Genmed. MM has consulted for F. Hoffmann-La Roche Ltd and is a member of the Scientific Advisory Board of Biomarkers of Araclon. MT, EB, CG, GK are full-time employees, and owns stock or stock options, of F. Hoffmann-La Roche Ltd. NRV, SB, EPM, ES are full-time employees of Life Molecular Imaging GmbH. The rest of authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}